Target delineation and radiotherapy for IDH-mutant WHO CNS grade 2 and 3 diffuse glioma - ESTRO | Cliniscan
Cliniscan
Solutions
Tarifs
Ressources
Se connecter
Essayer gratuitement
Cliniscan
Retour aux recommandations
ESTRO
2025
·
Europe
·
Oncology
Target delineation and radiotherapy for IDH-mutant WHO CNS grade 2 and 3 diffuse glioma
Document
Analyser ce document
